106 related articles for article (PubMed ID: 1649602)
1. Is decavanadate a specific inositol 1,4,5-trisphosphate receptor antagonist?
Strupish J; Wojcikiewicz RJ; Challiss RA; Safrany ST; Willcocks AL; Potter BV; Nahorski SR
Biochem J; 1991 Jul; 277 ( Pt 1)(Pt 1):294. PubMed ID: 1649602
[No Abstract] [Full Text] [Related]
2. Purification of the inositol1,4,5-trisphosphate receptor by heparin affinity chromatography using decavandate.
Richardson A; Taylor C
Biochem Soc Trans; 1992 May; 20(2):135S. PubMed ID: 1327899
[No Abstract] [Full Text] [Related]
3. Decavanadate displaces inositol 1,4,5-trisphosphate (IP3) from its receptor and inhibits IP3 induced Ca2+ release in permeabilized pancreatic acinar cells.
Föhr KJ; Wahl Y; Engling R; Kemmer TP; Gratzl M
Cell Calcium; 1991 Nov; 12(10):735-42. PubMed ID: 1663003
[TBL] [Abstract][Full Text] [Related]
4. Prolonged stimulation of SH-SY5Y cells with carbachol inhibits inositol 1,4,5-trisphosphate (InsP3) binding and InsP3-induced Ca2+ mobilisation.
Wojcikiewicz RJ; Nahorski SR
Biochem Soc Trans; 1991 Apr; 19(2):97S. PubMed ID: 1653744
[No Abstract] [Full Text] [Related]
5. Prolonged exposure to inositol 1,4,5-trisphosphate does not cause intrinsic desensitization of the intracellular Ca(2+)-mobilizing receptor.
Oldershaw KA; Richardson A; Taylor CW
J Biol Chem; 1992 Aug; 267(23):16312-6. PubMed ID: 1322898
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Ins(1,4,5)P3 receptors from rat cerebellum and bovine adrenal cortex.
White AM; Varney MA; Maeda N; Mikoshiba K; Watson SP
Biochim Biophys Acta; 1993 Feb; 1175(3):307-11. PubMed ID: 8382083
[TBL] [Abstract][Full Text] [Related]
7. Intracellular recognition sites for inositol 1,4,5-triphosphate and inositol 1,3,4,5-tetrakisphosphate.
Challiss RA; Safrany ST; Potter BV; Nahorski SR
Biochem Soc Trans; 1991 Nov; 19(4):888-93. PubMed ID: 1665446
[No Abstract] [Full Text] [Related]
8. Are there subtypes of the inositol 1,4,5-trisphosphate receptor?
Varney MA; Rivera J; Lopez Bernal A; Watson SP
Biochem J; 1990 Jul; 269(1):211-6. PubMed ID: 2165396
[TBL] [Abstract][Full Text] [Related]
9. The role of the 2- and 3-hydroxyl groups of 1D-myo-inositol 1,4,5-trisphosphate in the mobilisation of calcium from permeabilised human 1321N1 astrocytoma cells.
Wilcox RA; Nahorski SR; Sawyer DA; Liu C; Potter BV
Carbohydr Res; 1992 Oct; 234():237-46. PubMed ID: 1334801
[TBL] [Abstract][Full Text] [Related]
10. Postnatal expression of the inositol 1,4,5-trisphosphate receptor in canine cerebellum.
Volpe P; Sacchetto R; Alderson-Lang BH
Int J Biochem; 1992 Oct; 24(10):1525-32. PubMed ID: 1327888
[TBL] [Abstract][Full Text] [Related]
11. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor.
Safrany ST; Wilcox RA; Liu C; Dubreuil D; Potter BV; Nahorski SR
Mol Pharmacol; 1993 Apr; 43(4):499-503. PubMed ID: 8386304
[TBL] [Abstract][Full Text] [Related]
12. Calcium-induced degradation of the inositol (1,4,5)-trisphosphate receptor/Ca(2+)-channel.
Magnusson A; Haug LS; Walaas SI; Ostvold AC
FEBS Lett; 1993 Jun; 323(3):229-32. PubMed ID: 8388808
[TBL] [Abstract][Full Text] [Related]
13. Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400.
Furuichi T; Yoshikawa S; Miyawaki A; Wada K; Maeda N; Mikoshiba K
Nature; 1989 Nov; 342(6245):32-8. PubMed ID: 2554142
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of [3H]inositol 1,4,5-trisphosphate binding sites in adrenal-cortical membranes. Characterization and validation of a radioreceptor assay.
Challiss RA; Chilvers ER; Willcocks AL; Nahorski SR
Biochem J; 1990 Jan; 265(2):421-7. PubMed ID: 2154189
[TBL] [Abstract][Full Text] [Related]
15. Solubilization and partial characterization of inositol 1,4,5-trisphosphate receptor of bovine adrenal cortex reveal similarities with the receptor of rat cerebellum.
Guillemette G; Favreau I; Boulay G; Potier M
Mol Pharmacol; 1990 Dec; 38(6):841-7. PubMed ID: 2174504
[TBL] [Abstract][Full Text] [Related]
16. 2-Hydroxyethyl alpha-D-glucopyranoside 2,3',4'-trisphosphate: a novel metabolically resistant adenophostin A and myo-inositol 1,4,5-trisphosphate analogue potently interacts with the myo-inositol 1,4,5-trisphosphate receptor.
Wilcox RA; Erneux C; Primrose WU; Gigg R; Nahorski SR
Biochem Soc Trans; 1995 Aug; 23(3):420S. PubMed ID: 8566308
[No Abstract] [Full Text] [Related]
17. [3H]inositol trisphosphate specific binding in cerebella of mouse lines selectively bred for differential ethanol sensitivity.
Morrow EL; Erwin VG; Smith TL
Proc West Pharmacol Soc; 1988; 31():269-71. PubMed ID: 2850559
[No Abstract] [Full Text] [Related]
18. Inositol 1:2-cyclic,4,5-trisphosphate is only a weak agonist at inositol 1,4,5-trisphosphate receptors.
Willcocks AL; Strupish J; Irvine RF; Nahorski SR
Biochem J; 1989 Jan; 257(1):297-300. PubMed ID: 2537626
[TBL] [Abstract][Full Text] [Related]
19. Low concentrations of adenine nucleotides enhance the receptor binding of inositol 1,4,5-trisphosphate.
Spät A; Eberhardt I; Kiesel L
Biochem J; 1992 Oct; 287 ( Pt 1)(Pt 1):335-6. PubMed ID: 1329731
[No Abstract] [Full Text] [Related]
20. Influence of Mg2+ and pH on n.m.r. spectra and radioligand binding of inositol 1,4,5-trisphosphate.
White AM; Varney MA; Watson SP; Rigby S; Liu CS; Ward JG; Reese CB; Graham HC; Williams RJ
Biochem J; 1991 Sep; 278 ( Pt 3)(Pt 3):759-64. PubMed ID: 1654891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
